GLG Partners’s Bausch Health BHC Stock Holding History

GLG Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$789K	–	429
2016 Q1	$789K	Buy	+30,000	New	+$2.22M	0.02%	333

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GLG Partners's BHC Position: Q4 2016 in Review

GLG Partners sold out of Bausch Health (BHC) in Q4 2016, closing a stake of 276,408 shares — an estimated $6.79M sold.

GLG Partners first reported a position in BHC in Q1 2014 and held it in 11 quarters. The position peaked at $18M in Q4 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2016.

GLG Partners reported no remaining Bausch Health position as of Q4 2016 after selling out during the quarter.
GLG Partners sold 276,408 Bausch Health shares in Q4 2016, an estimated $6.79M.
GLG Partners first reported a position in Bausch Health in Q1 2014 and held it in 11 quarters.
GLG Partners's Bausch Health position peaked at $18M in Q4 2015.
315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.